Abstract
Tumour necrosis factors, TNF-α and TNF-β (previously called lymphotoxin), are the products of activated monocytes and lymphocytes, respectively, and both have recently been purified, sequenced and cloned by recombinant DNA methods1–5, revealing 35% identity and 50% homology in the amino-acid sequence. Both proteins have been found to be specifically toxic to many tumour cells. Furthermore, it has been reported that various interferons are synergistic with TNF for anti-tumour effects in vitro6–8, while activities attributed to the two proteins have also been shown to necrotize various tumours in vivo2,3,9. We have now prepared 125I-labelled highly purified recombinant human TNF-α to study in detail its binding to the human cervical carcinoma cell line ME-180. Our results indicate that there is a single class of specific high-affinity receptors for TNF on this cell line which has a Kd of about 0.2 nM and an average of 2,000 receptor sites per cell. The binding of labelled TNF-α to these cells can be inhibited by both TNF-α and TNF-β but not by γ-interferon (IFN-γ). However, preincubation of cells with IFN-γ increases the total number of TNF receptors two to threefold without any significant change in the affinity constant. This is the first report that TNF-α and -β share a common receptor and that the receptors can be up-regulated by interferon. Our results may explain previous observations regarding similar biological activities observed for these two cytotoxic proteins and also their synergistic action with interferons.
Similar content being viewed by others
References
Aggarwal, B. B., Moffat, B. & Harkins, R. N. J. biol. Chem. 259, 686–691 (1984).
Gray, P. W. et al. Nature 312, 721–724 (1984).
Pennica, D. et al. Nature 312, 724–729 (1984).
Aggarwal, B. B., Henzel, W. J., Kohr, W. J. & Harkins, R. N. J. biol. Chem. 260, 2334–2344 (1985).
Aggarwal, B. B. et al. J. biol Chem. 260, 2345–2355 (1985).
Stone-Wolff, D. S. et al. J. exp. Med. 159, 828–843 (1984).
Aggarwal, B. B., Moffat, B., Lee, S. H. & Harkins, R. N. in Thymic Hormones and Lymphokines (ed. Goldstein, A. L.) 235–245 (Plenum, New York, 1984).
Lee, S. H., Aggarwal, B. B., Rinderknecht, E., Assisi, F. & Chiu, H. J. Immun. 133, 1083–1086 (1984).
Carswell, E. A. et al. Proc. natn. Acad. Sci. U.S.A. 72, 3666–3670 (1975).
Fraker, P. J. & Speck, J. C. Biochem. biophys. Res. Commun. 80, 849–857 (1978).
Williams, T. W., Tremble, P. & Antoniades, H. N. Proc. natn. Acad. sci. U.S.A. 79, 5867–5870 (1982).
Branca, A. A. & Baglioni, C. Nature 294, 768–770 (1981).
Buckley, D. I. & Ramachandran, J. Proc. natn. Acad. sci. U.S.A. 78, 7431–7435 (1981).
Shalaby, M. R. et al. J. Immun. 135, 2069–2072 (1985).
Czarniecki, C. W., Fennie, C. W., Powers, D. B. & Estell, D. A. J. Virol. 49, 490–496 (1984).
Svedersky, L. P. et al. J. Immun. 133, 714–718 (1984).
Laemmli, U. K. Nature 227, 680–685 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aggarwal, B., Eessalu, T. & Hass, P. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318, 665–667 (1985). https://doi.org/10.1038/318665a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/318665a0
- Springer Nature Limited
This article is cited by
-
COVID-19-associated pulmonary aspergillosis in immunocompetent patients: a virtual patient cohort study
Journal of Mathematical Biology (2023)
-
Evidence that TNF-β suppresses osteoblast differentiation of mesenchymal stem cells and resveratrol reverses it through modulation of NF-κB, Sirt1 and Runx2
Cell and Tissue Research (2020)
-
The many faces of tumor necrosis factor signaling in the intestinal epithelium
Genes & Immunity (2019)
-
T cell-derived lymphotoxin limits Th1 response during HSV-1 infection
Scientific Reports (2018)
-
A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis
Scientific Reports (2015)